Micron Biomedical recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation.
The Wistar Institute and Batavia Biosciences have launched a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commonly known as RA 27/3.
WHO had declared Sri Lanka as Malaria-free country in 2015, Filaria-free country in 2016 and Maternal and Neonatal Tetanus (MNT) -free country in 2017.